These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 21569168)

  • 1. Cost-effectiveness of point-of-care biomarker assessment for suspected myocardial infarction: the randomized assessment of treatment using panel Assay of cardiac markers (RATPAC) trial.
    Fitzgerald P; Goodacre SW; Cross E; Dixon S
    Acad Emerg Med; 2011 May; 18(5):488-95. PubMed ID: 21569168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The RATPAC (Randomised Assessment of Treatment using Panel Assay of Cardiac markers) trial: a randomised controlled trial of point-of-care cardiac markers in the emergency department.
    Goodacre S; Bradburn M; Fitzgerald P; Cross E; Collinson P; Gray A; Hall AS
    Health Technol Assess; 2011 May; 15(23):iii-xi, 1-102. PubMed ID: 21616014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interhospital variation in the RATPAC trial (Randomised Assessment of Treatment using Panel Assay of Cardiac markers).
    Bradburn M; Goodacre SW; Fitzgerald P; Coats T; Gray A; Hassan T; Humphrey J; Kendall J; Smith J; Collinson P;
    Emerg Med J; 2012 Mar; 29(3):233-8. PubMed ID: 21617159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised Assessment of Treatment using Panel Assay of Cardiac markers--Contemporary Biomarker Evaluation (RATPAC CBE).
    Collinson PO; Gaze DC; Thokala P; Goodacre S
    Health Technol Assess; 2013; 17(15):v-vi, 1-122. PubMed ID: 23597479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Randomised Assessment of Treatment using Panel Assay of Cardiac Markers (RATPAC) trial: a randomised controlled trial of point-of-care cardiac markers in the emergency department.
    Goodacre SW; Bradburn M; Cross E; Collinson P; Gray A; Hall AS;
    Heart; 2011 Feb; 97(3):190-6. PubMed ID: 20884788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Very early diagnosis of chest pain by point-of-care testing: comparison of the diagnostic efficiency of a panel of cardiac biomarkers compared with troponin measurement alone in the RATPAC trial.
    Collinson P; Goodacre S; Gaze D; Gray A;
    Heart; 2012 Feb; 98(4):312-8. PubMed ID: 22076016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-sensitivity troponin assays for early rule-out of acute myocardial infarction in people with acute chest pain: a systematic review and economic evaluation.
    Westwood M; Ramaekers B; Grimm S; Worthy G; Fayter D; Armstrong N; Buksnys T; Ross J; Joore M; Kleijnen J
    Health Technol Assess; 2021 May; 25(33):1-276. PubMed ID: 34061019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 2-h diagnostic protocol to assess patients with chest pain symptoms in the Asia-Pacific region (ASPECT): a prospective observational validation study.
    Than M; Cullen L; Reid CM; Lim SH; Aldous S; Ardagh MW; Peacock WF; Parsonage WA; Ho HF; Ko HF; Kasliwal RR; Bansal M; Soerianata S; Hu D; Ding R; Hua Q; Seok-Min K; Sritara P; Sae-Lee R; Chiu TF; Tsai KC; Chu FY; Chen WK; Chang WH; Flaws DF; George PM; Richards AM
    Lancet; 2011 Mar; 377(9771):1077-84. PubMed ID: 21435709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delta creatine kinase-MB outperforms myoglobin at two hours during the emergency department identification and exclusion of troponin positive non-ST-segment elevation acute coronary syndromes.
    Fesmire FM; Christenson RH; Fody EP; Feintuch TA
    Ann Emerg Med; 2004 Jul; 44(1):12-9. PubMed ID: 15226704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic review, meta-analysis and economic modelling of diagnostic strategies for suspected acute coronary syndrome.
    Goodacre S; Thokala P; Carroll C; Stevens JW; Leaviss J; Al Khalaf M; Collinson P; Morris F; Evans P; Wang J
    Health Technol Assess; 2013; 17(1):v-vi, 1-188. PubMed ID: 23331845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact from point-of-care devices on emergency department patient processing times compared with central laboratory testing of blood samples: a randomised controlled trial and cost-effectiveness analysis.
    Asha SE; Chan AC; Walter E; Kelly PJ; Morton RL; Ajami A; Wilson RD; Honneyman D
    Emerg Med J; 2014 Sep; 31(9):714-9. PubMed ID: 23748157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The incremental benefit of a shortness-of-breath biomarker panel in emergency department patients with dyspnea.
    Singer AJ; Thode HC; Green GB; Birkhahn R; Shapiro NI; Cairns C; Baumann BM; Aghababian R; Char D; Hollander JE
    Acad Emerg Med; 2009 Jun; 16(6):488-94. PubMed ID: 19388909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomised controlled trial of the Limit of Detection of Troponin and ECG Discharge (LoDED) strategy versus usual care in adult patients with chest pain attending the emergency department: study protocol.
    Carlton E; Campbell S; Ingram J; Kandiyali R; Taylor H; Aziz S; Beresford P; Kendall J; Reuben A; Smith J; Vickery PJ; Benger JR
    BMJ Open; 2018 Oct; 8(10):e025339. PubMed ID: 30282688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aiming toWards Evidence baSed inTerpretation of Cardiac biOmarkers in patients pResenting with chest pain using Point of Care Testing (WESTCOR-POC): study design.
    Thulin IVL; Jordalen SMF; Lekven OC; Krishnapillai J; Steiro OT; Collinson P; Apple F; Cullen L; Norekvål TM; Wisløff T; Vikenes K; Omland T; Bjørneklett RO; Aakre KM
    Scand Cardiovasc J; 2023 Dec; 57(1):2272585. PubMed ID: 37905548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk stratification of chest pain patients by point-of-care cardiac troponin T and myoglobin measured in the emergency department.
    Ordóñez-Llanos J; Santaló-Bel M; Mercé-Muntañola J; Collinson PO; Gaze D; Haass M; Katus HA; Chwallek F; Hirschl MM; Derhaschnig U; Mueller-Bardorff M; Kellett J; Sylvén C; Schulz I; Zerback R;
    Clin Chim Acta; 2006 Mar; 365(1-2):93-7. PubMed ID: 16214122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid risk stratification in suspected acute coronary syndrome using serial multiple cardiac biomarkers: a pilot study.
    Macdonald SP; Nagree Y
    Emerg Med Australas; 2008 Oct; 20(5):403-9. PubMed ID: 18973637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergency department triage strategies for acute chest pain using creatine kinase-MB and troponin I assays: a cost-effectiveness analysis.
    Polanczyk CA; Kuntz KM; Sacks DB; Johnson PA; Lee TH
    Ann Intern Med; 1999 Dec; 131(12):909-18. PubMed ID: 10610641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of myoglobin, troponin T, and CK-MBmass in ruling out an acute myocardial infarction in the emergency room.
    de Winter RJ; Koster RW; Sturk A; Sanders GT
    Circulation; 1995 Dec; 92(12):3401-7. PubMed ID: 8521560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A miscarriage of justice in the RATPAC trial?
    Wardrop R
    Heart; 2012 Jan; 98(2):170; author reply 170-1. PubMed ID: 22128209
    [No Abstract]   [Full Text] [Related]  

  • 20. Estimating the clinical impact of bringing a multimarker cardiac panel to the bedside in the ED.
    Birkhahn RH; Haines E; Wen W; Reddy L; Briggs WM; Datillo PA
    Am J Emerg Med; 2011 Mar; 29(3):304-8. PubMed ID: 20825823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.